Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$8.63 - $12.56 $52,643 - $76,616
-6,100 Reduced 16.27%
31,400 $292,000
Q1 2024

May 07, 2024

SELL
$9.86 - $13.74 $135,082 - $188,238
-13,700 Reduced 26.76%
37,500 $463,000
Q4 2023

Feb 14, 2024

SELL
$7.1 - $10.89 $148,390 - $227,601
-20,900 Reduced 28.99%
51,200 $557,000
Q3 2023

Nov 14, 2023

BUY
$6.95 - $9.89 $164,715 - $234,393
23,700 Added 48.97%
72,100 $576,000
Q2 2023

Aug 11, 2023

BUY
$8.59 - $14.56 $108,234 - $183,456
12,600 Added 35.2%
48,400 $464,000
Q1 2023

May 16, 2023

SELL
$9.53 - $16.8 $57,179 - $100,800
-6,000 Reduced 14.35%
35,800 $429,000
Q4 2022

Feb 14, 2023

BUY
$8.71 - $14.28 $234,299 - $384,132
26,900 Added 180.54%
41,800 $581,000
Q3 2022

Nov 14, 2022

BUY
$7.19 - $9.91 $107,131 - $147,659
14,900 New
14,900 $135,000
Q4 2021

Feb 14, 2022

BUY
$8.71 - $13.77 $255,203 - $403,461
29,300 Added 113.13%
55,200 $550,000
Q3 2021

Nov 15, 2021

SELL
$10.35 - $15.65 $1.05 Million - $1.59 Million
-101,400 Reduced 79.65%
25,900 $295,000
Q2 2021

Aug 11, 2021

BUY
$12.25 - $14.87 $1 Million - $1.22 Million
81,900 Added 180.4%
127,300 $1.98 Million
Q1 2021

May 17, 2021

SELL
$12.28 - $19.74 $593,124 - $953,441
-48,300 Reduced 51.55%
45,400 $693,000
Q4 2020

Feb 16, 2021

BUY
$11.65 - $17.94 $173,585 - $267,306
14,900 Added 18.91%
93,700 $1.26 Million
Q3 2020

Nov 16, 2020

BUY
$12.98 - $25.98 $429,638 - $859,938
33,100 Added 72.43%
78,800 $1.38 Million
Q2 2020

Aug 14, 2020

BUY
$9.06 - $23.49 $35,334 - $91,611
3,900 Added 9.33%
45,700 $1.14 Million
Q1 2020

May 15, 2020

BUY
$7.2 - $13.09 $300,960 - $547,162
41,800 New
41,800 $463,000

Others Institutions Holding ZYXI

About ZYNEX INC


  • Ticker ZYXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 37,453,400
  • Market Cap $293M
  • Description
  • Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...
More about ZYXI
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.